Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Neurobiology of Disease|June 13, 2006
Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 miceArianna Bellucci, Ilaria Luccarini, Carla Scali, et al.Neurobiology of Aging|May 16, 2002
Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's diseaseCarla Scali, Costanza Prosperi, Laura Bracco, et al.Neurobiology of Disease|December 31, 2002
Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathwayMaria Grazia Giovannini, Carla Scali, Costanza Prosperi, et al.Neurobiology of Disease|August 22, 2006
Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1Carla Scali, Filippo Caraci, Marco Gianfriddo, et al.Neurobiology of Disease|December 3, 2015
Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discoveryIlaria Ceccarelli, Pasquale Fiengo, Rosaria Remelli, et al.Journal of Neurochemistry|January 7, 2010
Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative diseaseMaria Cristina Rosi, Ilaria Luccarini, Cristina Grossi, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 12, 2011
VSTM2L is a novel secreted antagonist of the neuroprotective peptide HumaninLara Rossini, Yuichi Hashimoto, Hiroaki Suzuki, et al.International Journal of Molecular Sciences|January 26, 2021
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral NeurotoxicityCristina Meregalli, Laura Monza, Alessia Chiorazzi, et al.Bioorganic & Medicinal Chemistry|June 12, 2009
SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonistSimon N Haydar, Chiara Ghiron, Laura Bettinetti, et al.The Journal of Pharmacology and Experimental Therapeutics|February 19, 2009
Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disordersRenza Roncarati, Carla Scali, Thomas A Comery, et al.Pageof 2